Skip Navigation

Nucleic Acids Research 2004 32(15):4480-4490; doi:10.1093/nar/gkh773
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (262K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Godefroy, N.
Right arrow Articles by Vayssière, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Godefroy, N.
Right arrow Articles by Vayssière, J.-L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published online 23 August 2004

Nucleic Acids Research, Vol. 32 No. 15 © Oxford University Press 2004; all rights reserved

Transcriptional repression by p53 promotes a Bcl-2-insensitive and mitochondria-independent pathway of apoptosis

Nelly Godefroy, Sylvina Bouleau, Gaëtan Gruel1, Flore Renaud, Vincent Rincheval, Bernard Mignotte, Diana Tronik-Le Roux1 and Jean-Luc Vayssière*

Université de Versailles/Saint Quentin-en-Yvelines, FRE 2445, Laboratoire de Génétique et Biologie Cellulaire and Ecole Pratique des Hautes Etudes, Laboratoire de Génétique Moléculaire et Physiologique, 45 avenue des Etats-Unis, 78035 Versailles cedex, France and 1 Commissariat à l'Energie Atomique (CEA), Laboratoire de Génomique et Radiobiologie de l'Hématopoïèse, Service de Génomique Fonctionnelle, 2 rue Gaston Crémieux 91057 Evry, France

* To whom correspondence should be addressed. Tel: +33 1 39 25 36 60; Fax: +33 1 39 25 36 55; Email: vayssiere{at}genetique.uvsq.fr

Received June 18, 2004; Revised and Accepted July 28, 2004

p53 can induce apoptosis in various ways including transactivation, transrepression and transcription-independent mechanisms. What determines the choice between them is poorly understood. In a rat embryo fibroblast model, caspase inhibition changed the outcome of p53 activation from standard Bcl-2-regulated apoptosis to caspase-independent and Bcl-2-insensitive cell death, a phenomenon not described previously. Here, we show that caspase inhibition affects cell death commitment decisions by modulating the apoptotic functions of p53. Indeed, in the Bcl-2-sensitive pathway, transactivation-dependent signalling is activated leading to a rapid MDM2-mediated degradation of p53. In contrast, in the Bcl-2-insensitive pathway, p53 is stable and this is associated with transrepression-dependent signalling. A study with microarrays identified these genes regulated by p53 in the absence of active caspases.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BloodHome page
B. Jacquelin, T. Kortulewski, P. Vaigot, A. Pawlik, G. Gruel, O. Alibert, P. Soularue, C. Joubert, X. Gidrol, and D. T.-L. Roux
Novel pathway for megakaryocyte production after in vivo conditional eradication of integrin {alpha}IIb-expressing cells
Blood, September 15, 2005; 106(6): 1965 - 1974.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.